The study presents an explainable multimodal deep‑learning framework that combines a 3D CNN for T1‑weighted MRI with a feedforward network for harmonized clinical and demographic data to diagnose Alzheimer’s disease. Using 6,479 ADNI records and 1,703 OASIS‑3 records, the authors compare various model configurations on three‑way and pairwise diagnostic tasks, finding that performance and explanations vary by task, modality, fusion strategy, and cohort. SHAP and Integrated Gradients consistently highlight the MMSE score as the most influential tabular feature, while CAM‑based explanations differ across model setups and cohorts, indicating that explainability is not a stable property under cohort shift.
By Yusuf Brima, Marcellin Atemkeng, Lakshmana Rao Namamula, Antoine Vacavant
In longitudinal Alzheimer's disease (AD) diagnosis support, clinical and imaging information is often collected at irregular visits. Integrating these multimodal observations may improve diagnostic assessment, but naive fusion can degrade performance when MRI is noisy or intermittently unavailable.
arXiv:2607. 07091v1 Announce Type: cross Abstract: In longitudinal Alzheimer's disease (AD) diagnosis support, clinical and imaging information is often collected at irregular visits.
By Xinyue Du, Yibo Liu, Zhenglei Zhou, Xuancheng Yao, Weimin Zhong, Qiuhui Chen
arXiv:2610.10648v1 Announce Type: new
Abstract: Alzheimer's disease prediction involves irregular visits, heterogeneous measurements and incomplete modalities. This study presents a multimodal multit...
By Akeem Temitope Otapo, Ghazaleh Khodabandelou, Zuheng Ming, Alice Othmani
arXiv:2609.15888v1 Announce Type: cross
Abstract: Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irreleva...
By Paul-Gabriel Nicolae, Irina Georgiana Mocanu
arXiv:2606. 17867v1 Announce Type: cross Abstract: Despite increasing adoption of multimodal approaches in Alzheimer's Disease (AD) research -- aimed at integrating molecular, structural, clinical, and genetic biomarkers to enhance disease characterization -- the relationships among these modalities remain poorly understood.
By Antonio Scardace, Daniele Rav\`i
arXiv:2607. 11656v1 Announce Type: cross Abstract: Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of real-world clinical data.
By Christelle Schneuwly Diaz, Narmina Baghirova, Duy-Thanh Vu, Duy-Cat Can, Gilles Allali, Philippe Ryvlin, Oliver Y. Ch\'en
The paper presents a multimodal 3D convolutional neural network that classifies Alzheimer’s disease using raw OASIS 1 MRI volumes. It fuses structural T1 images with gray matter, white matter, and cerebrospinal fluid probability maps to capture complementary neuroanatomical information. Evaluated with 5‑fold subject‑level cross‑validation, the model achieves a mean accuracy of 72.34 % and an ROC AUC of 0.7781, with GradCAM visualizations highlighting anatomically relevant regions such as the medial temporal lobe and ventricles.
By Md Sifat, Sania Akter, Akif Islam, Md. Ekramul Hamid, Abu Saleh Musa Miah, Najmul Hassan, Md Abdur Rahim, Jungpil Shin
arXiv:2606. 20037v1 Announce Type: new Abstract: Alzheimer's disease (AD) is an irreversible neurodegenerative disorder and a leading cause of death worldwide.
By Loukas Ilias, Anthi-Maria Vozinaki, Christos Ntanos, Dimitris Askounis
MMAP is a Multimodal Missing‑Aware Alignment Pretraining method designed to learn image‑tabular representations from incomplete data. It uses a sigmoid contrastive learning image encoder with generative reconstruction, a tabular encoder based on a foundation model, and a missing token generator to handle missing modalities. The approach is evaluated on longitudinal Alzheimer’s tasks—predicting disease stage conversion and amyloid status—and outperforms both multimodal and unimodal baselines.
By Fiona Kekwick, Matthew Baugh, Bernhard Kainz, Paul M. Matthews, Wenjia Bai
The paper introduces TAFNet, a temporal attention fusion network that uses both a baseline and a follow‑up T1‑weighted brain scan to predict which individuals with mild cognitive impairment (MCI) will progress to dementia. The model employs a pretrained Siamese encoder for each scan and fuses the two scans through anatomical difference, cross‑temporal attention, joint context, and a learned per‑patient gate. Evaluated on paired scans from the Alzheimer’s Disease Neuroimaging Initiative, TAFNet outperforms single‑scan networks and a simple scan‑difference model, achieving significant gains in cross‑validation and maintaining high sensitivity at clinically reasonable specificity.
By Sara Fin, Alireza Moayedikia, David J. White, Uffe Kock Wiil, Alicia Troncoso
arXiv:2606. 03995v1 Announce Type: cross Abstract: Background: Alzheimer's disease (AD) affects over 55 million people worldwide.
By Afshan Hashmi